ROKA and IRONMAN Expand Relationship with Global Partnership
IRONMAN, a Wanda Sports Holdings company, announced today a multi-year global partnership that expands its relationship with ROKA, the Austin-based performance multisport brand. This new partnership makes ROKA the Official Global Wetsuit and Swim Partner of IRONMAN® and the IRONMAN World Championship and IRONMAN 70.3® World Championship events.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180531006432/en/
The most inspiring swim start in all of triathlon. #FindFaster #IMKona (Photo: Business Wire)
The partnership between IRONMAN and ROKA will further a relationship that began in 2014. Besides an expanded physical presence at IRONMAN events across the globe, ROKA and IRONMAN are collaborating on IRONMAN World Championship swim products this October in honor of IRONMAN’s 40th Anniversary. Additionally, ROKA will now sell co-branded swim products online via www.ironmanstore.com and roka.com, and will continue to give out the ROKA Fastest Swimmer Award to congratulate the fastest age group athlete during each event’s swim.
“We’re thrilled to expand our partnership with IRONMAN,” said ROKA CEO and Co-Founder Rob Canales. “IRONMAN is the best in the world at providing the ultimate endurance race experience, and ROKA is the best in the world at supporting those athletes with technical products that meet the demands of the day. We’re excited to collaborate with IRONMAN on new products and services and to immediately bring our existing ones to more athletes around the world.”
In the last six years, ROKA has designed the world’s most advanced high-performance wetsuits, goggles, eyewear, swimskins and race apparel, which have been worn to numerous world titles and over 50 IRONMAN and IRONMAN 70.3 wins by the world’s best triathletes, including Javier Gómez Noya, Lucy Charles, Tim Reed, Melissa Hauschildt, Luke McKenzie, Meredith Kessler, Linsey Corbin, Jesse Thomas and more. With this new partnership, IRONMAN athletes will be able to sample ROKA’s groundbreaking technology before they buy at each IRONMAN event in the IRONMAN Village and have exclusive access to new products during the lead up to their races.
“I first tried ROKA’s Maverick wetsuit and Viper swimskin in 2014 and have been using both ever since, however the products have at times been difficult to find outside the U.S.” said Javier Gómez Noya, two-time IRONMAN 70.3 World Champion who splits time between Spain and New Zealand. “With this expanded partnership, IRONMAN athletes from around the globe can now get their hands on the cutting-edge technology that has been my secret weapon for the past four years.”
Just six years from its humble beginnings in a garage in Austin, ROKA has grown to become the wetsuit and swimwear choice of countless triathletes and hundreds of multisport teams around the world, and its Viper swimskin has been trusted by more athletes at the IRONMAN World Championships than any other brand for multiple years running.
“ROKA embodies the spirit of innovation and ingenuity that aligns well with the needs of our athletes,” said Matthieu Van Veen, Chief Revenue Officer for IRONMAN. “We are eager to expand this partnership to cover all of our events globally and bring ROKA’s swimwear products to our athletes around the world.”
In 2018, ROKA will have a presence across the IRONMAN® and IRONMAN 70.3® Series, including 40 races in North America, 32 in Europe, and 13 in Oceania, as well as the IRONMAN World Championship and IRONMAN 70.3 World Championship. Each IRONMAN race consists of a 2.4-mile swim, 112-mile bike and 26.2-mile run while the IRONMAN 70.3 race series events consist of a 1.2-mile swim, 56-mile bike and 13.1-mile run.
For more information on the IRONMAN brand and global event series, visit www.ironman.com.
Find out more about ROKA at roka.com.
ROKA started in a garage in Austin, Texas with humble beginnings and laser-beam focus. ROKA’s mission is to unlock human potential. To equip, empower, inspire and ignite. ROKA serves those who seek to redefine the standard, to push themselves to the limit – whatever and wherever that may be.
Since its launch in 2013, ROKA athletes have won over a dozen world titles and have been instrumental in the design and development of an unprecedented collection of patented and award-winning products. In 2016, ROKA was proud to send 18 athletes to the Rio Olympics, taking home Gold and Bronze. In PyeongChang, ROKA continued the tradition, taking home Olympic Gold and Bronze in their Advanced Performance eyewear. 2018 has seen elite athletes around the globe in running, cycling, triathlon, speed skating, beach volleyball, and off-road endurance events trusting ROKA eyewear for their most important performances on the biggest of stages.
ROKA products are available worldwide at www.roka.com and through select retailers. Visit us online to learn more about our growing lines of premium performance eyewear. Follow ROKA on social media at Facebook, Twitter, and Instagram.
A Wanda Sports Holdings company, IRONMAN operates a global portfolio of events that includes the IRONMAN® Triathlon Series, the IRONMAN® 70.3® Triathlon Series, 5150™ Triathlon Series, the Rock n’ Roll Marathon Series®, Iron Girl®, IRONKIDS®, International Triathlon Union World Triathlon Series races, road cycling events including the UCI Velothon® Series, mountain bike races including the Absa Cape Epic®, premier marathons including the Standard Chartered Singapore Marathon, and other multisport races. IRONMAN’s events, together with all other Wanda Sports Holdings events, provide more than a million participants annually the benefits of endurance sports through the company’s vast offerings. The iconic IRONMAN® Series of events is the largest participation sports platform in the world. Since the inception of the IRONMAN® brand in 1978, athletes have proven that ANYTHING IS POSSIBLE® by crossing finish lines at the world’s most challenging endurance races. Beginning as a single race, IRONMAN has grown to become a global sensation with more than 200 events across 50 countries. For more information, visit www.ironman.com.
About Wanda Sports Holdings
Wanda Sports Holdings is the world’s leading sports business entity, founded to capture the opportunities in the global sports industry and to contribute to the prosperous international sports landscape – in three key areas: 1) Spectator Sports (media and marketing business), 2) Participation Sports (active lifestyle business), 3) Services (digital, production and service business). Wanda Sports Holding incorporates the international sports marketing company Infront Sports & Media, the iconic endurance brand IRONMAN, and Wanda Sports China. The headquarters are in Guangzhou, China.
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza16.8.2018 05:00 | Pressemelding
BioNTech AG, a rapidly growing biotechnology company focused on precise immunotherapies for the treatment of cancer and infectious disease, today announced that it has entered into a multi-year research and development (R&D) collaboration with Pfizer Inc. (NYSE: PFE) to develop mRNA-based vaccines for prevention of influenza (flu). Under the terms of the agreement, BioNTech and Pfizer will jointly conduct research and development activities to help advance mRNA-based flu vaccines. Pfizer will assume sole responsibility for further clinical development and commercialization of mRNA-based flu vaccines, following BioNTech’s completion of a first in human clinical study. BioNTech will receive $120 million in upfront, equity and near-term research payments and up to an additional $305 million in potential development, regulatory and commercial milestone payments. In addition, BioNTech will receive up to double-digit tiered royalty payments associated with worldwide sales if the program reac
Maxion Wheels to Showcase Market-Leading Light Weight Commercial Vehicle Wheels at REIFEN 201816.8.2018 04:05 | Pressemelding
Maxion Wheels, the world’s largest producer of wheels, announced today its participation in REIFEN, the leading tire and wheel industry event in Europe, from Sept. 11 – 15, 2018 in Hall 12.1 / Stand D24. For the first time, REIFEN will be co-located with Automechanika Frankfurt at the Messe Frankfurt. “REIFEN is the premier event for European tire and wheel manufacturers and resellers, bringing us together to meet and collaborate on the important aftermarket themes of innovation, service and delivery,” stated Mark Gerardts, Vice President of Global Sales and Marketing, Maxion Wheels. “After a highly popular launch to truck and trailer OEMs in 2017, we’re excited to have the industry’s lightest mass production steel wheel now available to our aftermarket distributors. This wheel, along with several others, including our new 10.00W-20 wide base tubetype and tubeless heavy duty armored vehicles wheel are great examples of our continued efforts to bring our OE multi-application innovations
Lenovo Accelerates Turnaround with Back-to-Back, Double-Digit Quarterly Revenue Growth15.8.2018 23:40 | Pressemelding
Lenovo Group (HKSE: 0992) (PINK SHEETS: LNVGY) today announced results for its first fiscal quarter ended June 30, 2018. For the second straight quarter, Lenovo achieved strong double-digit growth in revenue year-on-year. Group revenue reached US$11.91 billion, up 19% year-on-year. The company also reported strong pre-tax income during the quarter of US$113 million, an improvement of US$182 million year-on-year, as profitability improved across all businesses. In the first fiscal quarter, Lenovo’s profit attributable to equity holders grew to US$77 million, up US$149 million year-over-year. Basic earnings per share in the first fiscal quarter was 0.65 US cents or 5.10 HK cents. “As we persistently execute our 3-wave strategy, all our businesses made solid improvements in both revenue and profitability. Lenovo has passed the turning point and entered a phase of ‘acceleration’ - accelerating the execution of our transformation strategy and accelerating the rising momentum in business per
CORRECTING and REPLACING Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy15.8.2018 22:37 | Pressemelding
Please replace the release with the following corrected version due to multiple revisions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005602/en/ New Ebola immunotherapy developed by SAB Biotherapeutics uses natural human polyclonal antibodies to combat disease. (Photo: SAB Biotherapeutics) The corrected release reads: EBOLA SUCCESSFULLY NEUTRALIZED BY LATEST GENERATION POLYCLONAL IMMUNOTHERAPY Promising new platform can rapidly respond to emerging infectious diseases Sioux Falls, SD, August 15, 2018 – SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases . The study was conducted at the Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of He
Ebola Successfully Neutralized by Latest Generation Polyclonal Immunotherapy15.8.2018 17:43 | Pressemelding
SAB Biotherapeutics, Inc. (SAB), a clinical-stage biopharmaceutical company, today announced that its anti-Ebola immunotherapy (SAB-139) provided “100% protection against a lethal dose of the Ebola virus” in a recent animal study published in The Journal of Infectious Diseases . The study was conducted by the National Interagency Confederation for Biological Research and other collaborators including United States Army Medical Research Institute of Infectious Diseases (USAMRIID) and the Naval Medical Research Center (NMRC). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005602/en/ New Ebola immunotherapy developed by SAB Biotherapeutics uses natural human polyclonal antibodies to combat disease. (Photo: SAB Biotherapeutics) According to the World Health Organization, Ebola virus disease (EVD), formerly known as Ebola hemorrhagic fever, is a severe, often fatal illness in humans with an average fatality rate around 50%.
Rimini Street Receives Asia-Pacific Stevie Award for Customer Service Innovation15.8.2018 17:05 | Pressemelding
Rimini Street, Inc. (Nasdaq: RMNI), a global provider of enterprise software products and services, and the leading third-party support provider for Oracle and SAP software products, today announced it has been honored with a Stevie® Award in the Innovation in Customer Service Management, Planning & Practice category for its ultra-responsive, premium level service in the Asia-Pacific region. This honor marks the Company’s 12th Stevie Award win this year, and the second consecutive year the Company has been recognized by the Asia-Pacific Stevie Awards. Rimini Street recently earned Stevie Awards in several categories, including Company of the Year from the 2018 American Business Awards® and Customer Service Department of the Year from the 2018 Stevie Awards for Sales & Customer Service. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180815005580/en/ Rimini Street Receives Asia-Pacific Stevie Award for Customer Service Innovat